Clinical Trial Update: Study of Gemcitabine, Oxaliplatin, and Paclitaxel in Patients With Refractory Germ Cell Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the combination of gemcitabine, oxaliplatin, and paclitaxel in patients with refractory germ cell carcinoma (testicular cancer); the tr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Germ Cell Neoplasm
• Testicular Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)
• OXALIPLATIN (Oxaliplatin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: University of Southern California | Conditions: Testicular Cancer, Germ Cell Neoplasm | Phase 2 | Status: COMPLETED